Skip to main content
Clinical Trials/JPRN-UMIN000030101
JPRN-UMIN000030101
Recruiting
未知

The study of gene and epigenetic modifications, bioelement and physical active substance on the patients with neurodegenerative diseases. - The study of gene and epigenetic modifications, bioelement and physical active substance on the patients with neurodegenerative diseases.

Gifu Pharmaceutical University0 sites100 target enrollmentDecember 1, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
eurodegenerative diseases
Sponsor
Gifu Pharmaceutical University
Enrollment
100
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 1, 2017
End Date
February 19, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • \<Amyotrophic lateral sclerosis (ALS)\> Exclude the following diseases. Other motor neuron disorders, motor neurophathy, cervical spondylosis, and inflammatory myopathy such as inclusion body myositis. \<Idiopathic basal ganglia calcification (IBGC)\> To exclude diseases which show calcification, because of some causes such as hypoparathyroism, pseudo hypoparathyroism, pseudopseudo hypoparathyroism (Albright's osteodystrophy), Down syndrome, collagen diseases, angiitis, infections, intoxication, trauma, radiation therapy and so on.

Outcomes

Primary Outcomes

Not specified

Similar Trials